Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma

R. S. Birnbaum, M. Muszynski, B. A. Roos

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We have recently reported the establishment of 16 series of calcitonin-producing transplantable rat medullary thyroid carcinoma. In the present study, these tumor series have been evaluated for the presence of somatostatin-like immunoreactivity. Each of the series contained detectable levels of both peptides. Immunoreactive somatostatin varied from less than 1 ng/mg of protein to almost 500 ng/mg of protein. The range of immunoreactive calcitonin was 0.3 to 30 μg/mg of protein. Although somatostatin-like immunoreactivity was always less than that of calcitonin, the levels in certain series were as high as those found in neural or endocrine tissues used for in vitro studies of somatostatin elaboration. No significant correlation was found between tissue levels of these two peptides. Two tumor lines were generated by initiation of tumor growth with cells from primary monolayer cultures. Levels of both immunoreactive calcitonin and somatostatin significantly differed from those of the parent lines, which were maintained by serial passage of tissue fragments only. Plasma somatostatin-like immunoreactivity assessed in two tumor series with high (149 ng/mg of protein) and low (1.5 ng/mg of protein) tissue levels was 3100 and 50 pg/ml, respectively. Gel filtration chromatography of tissue and blood extracts showed a predominant peak (>90%) of immunoreactive somatostatin eluting at the position of the native hormone. Three other peaks were resolved in the tissue extract with estimated molecular weights of 14.000, 8.700, and 5.000. The high level of somatostatinlike immunoreactivity and the presence of multiple large forms suggest that certain tumor lines will prove valuable for studies of somatostatin biosynthesis and secretion.

Original languageEnglish
Pages (from-to)4192-4196
Number of pages5
JournalCancer Research
Volume40
Issue number11
StatePublished - Jan 1 1980

Fingerprint

Somatostatin
Calcitonin
Tissue Extracts
Neoplasms
Proteins
Serial Passage
Peptides
Primary Cell Culture
Gel Chromatography
Molecular Weight
Medullary Thyroid cancer
somatostatin-like peptides
Hormones
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma. / Birnbaum, R. S.; Muszynski, M.; Roos, B. A.

In: Cancer Research, Vol. 40, No. 11, 01.01.1980, p. 4192-4196.

Research output: Contribution to journalArticle

Birnbaum, RS, Muszynski, M & Roos, BA 1980, 'Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma', Cancer Research, vol. 40, no. 11, pp. 4192-4196.
Birnbaum, R. S. ; Muszynski, M. ; Roos, B. A. / Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma. In: Cancer Research. 1980 ; Vol. 40, No. 11. pp. 4192-4196.
@article{fe66785547a74fc2821da335de629e59,
title = "Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma",
abstract = "We have recently reported the establishment of 16 series of calcitonin-producing transplantable rat medullary thyroid carcinoma. In the present study, these tumor series have been evaluated for the presence of somatostatin-like immunoreactivity. Each of the series contained detectable levels of both peptides. Immunoreactive somatostatin varied from less than 1 ng/mg of protein to almost 500 ng/mg of protein. The range of immunoreactive calcitonin was 0.3 to 30 μg/mg of protein. Although somatostatin-like immunoreactivity was always less than that of calcitonin, the levels in certain series were as high as those found in neural or endocrine tissues used for in vitro studies of somatostatin elaboration. No significant correlation was found between tissue levels of these two peptides. Two tumor lines were generated by initiation of tumor growth with cells from primary monolayer cultures. Levels of both immunoreactive calcitonin and somatostatin significantly differed from those of the parent lines, which were maintained by serial passage of tissue fragments only. Plasma somatostatin-like immunoreactivity assessed in two tumor series with high (149 ng/mg of protein) and low (1.5 ng/mg of protein) tissue levels was 3100 and 50 pg/ml, respectively. Gel filtration chromatography of tissue and blood extracts showed a predominant peak (>90{\%}) of immunoreactive somatostatin eluting at the position of the native hormone. Three other peaks were resolved in the tissue extract with estimated molecular weights of 14.000, 8.700, and 5.000. The high level of somatostatinlike immunoreactivity and the presence of multiple large forms suggest that certain tumor lines will prove valuable for studies of somatostatin biosynthesis and secretion.",
author = "Birnbaum, {R. S.} and M. Muszynski and Roos, {B. A.}",
year = "1980",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "4192--4196",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma

AU - Birnbaum, R. S.

AU - Muszynski, M.

AU - Roos, B. A.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - We have recently reported the establishment of 16 series of calcitonin-producing transplantable rat medullary thyroid carcinoma. In the present study, these tumor series have been evaluated for the presence of somatostatin-like immunoreactivity. Each of the series contained detectable levels of both peptides. Immunoreactive somatostatin varied from less than 1 ng/mg of protein to almost 500 ng/mg of protein. The range of immunoreactive calcitonin was 0.3 to 30 μg/mg of protein. Although somatostatin-like immunoreactivity was always less than that of calcitonin, the levels in certain series were as high as those found in neural or endocrine tissues used for in vitro studies of somatostatin elaboration. No significant correlation was found between tissue levels of these two peptides. Two tumor lines were generated by initiation of tumor growth with cells from primary monolayer cultures. Levels of both immunoreactive calcitonin and somatostatin significantly differed from those of the parent lines, which were maintained by serial passage of tissue fragments only. Plasma somatostatin-like immunoreactivity assessed in two tumor series with high (149 ng/mg of protein) and low (1.5 ng/mg of protein) tissue levels was 3100 and 50 pg/ml, respectively. Gel filtration chromatography of tissue and blood extracts showed a predominant peak (>90%) of immunoreactive somatostatin eluting at the position of the native hormone. Three other peaks were resolved in the tissue extract with estimated molecular weights of 14.000, 8.700, and 5.000. The high level of somatostatinlike immunoreactivity and the presence of multiple large forms suggest that certain tumor lines will prove valuable for studies of somatostatin biosynthesis and secretion.

AB - We have recently reported the establishment of 16 series of calcitonin-producing transplantable rat medullary thyroid carcinoma. In the present study, these tumor series have been evaluated for the presence of somatostatin-like immunoreactivity. Each of the series contained detectable levels of both peptides. Immunoreactive somatostatin varied from less than 1 ng/mg of protein to almost 500 ng/mg of protein. The range of immunoreactive calcitonin was 0.3 to 30 μg/mg of protein. Although somatostatin-like immunoreactivity was always less than that of calcitonin, the levels in certain series were as high as those found in neural or endocrine tissues used for in vitro studies of somatostatin elaboration. No significant correlation was found between tissue levels of these two peptides. Two tumor lines were generated by initiation of tumor growth with cells from primary monolayer cultures. Levels of both immunoreactive calcitonin and somatostatin significantly differed from those of the parent lines, which were maintained by serial passage of tissue fragments only. Plasma somatostatin-like immunoreactivity assessed in two tumor series with high (149 ng/mg of protein) and low (1.5 ng/mg of protein) tissue levels was 3100 and 50 pg/ml, respectively. Gel filtration chromatography of tissue and blood extracts showed a predominant peak (>90%) of immunoreactive somatostatin eluting at the position of the native hormone. Three other peaks were resolved in the tissue extract with estimated molecular weights of 14.000, 8.700, and 5.000. The high level of somatostatinlike immunoreactivity and the presence of multiple large forms suggest that certain tumor lines will prove valuable for studies of somatostatin biosynthesis and secretion.

UR - http://www.scopus.com/inward/record.url?scp=0018951402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018951402&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 4192

EP - 4196

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 11

ER -